NCT01405612View on ClinicalTrials.gov

Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Digestive System Disorders
Interventions
DRUG

Midazolam

Single oral administration on Day 1 or Day 5

DRUG

Ulimorelin

Intravenous infusion of 480 micrograms/kg on Days 1 to 5

Trial Locations (1)

BT2 7BA

BioKinetic Europe Ltd, Belfast

Sponsors

Lead Sponsor

Norgine
All Listed Sponsors
lead

Norgine

INDUSTRY